secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verastem, Inc. (VSTM)
CIK:        0001526119
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001104659-25-039098
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verastem raises $75M private placement for ovarian cancer drug launch and R&D
-----------------------------------------------------------------------------

- Gross proceeds of ~$75M from sale of 3.43M shares at $7.00 and 7.29M pre-funded warrants at $6.9999.
- Placement led by RTW Investments; includes BVF, Nantahala, Octagon, OrbiMed, Stonepine.
- Net proceeds to fund potential launch of avutometinib/defactinib in LGSOC, R&D for VS-7375, and working capital.
- Pre-funded warrants exercisable at $0.0001/share, no expiration; closing expected April 28, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1526119/000110465925039098/0001104659-25-039098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1526119/000110465925039098/tm2513177d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-039098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer